Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2020

View Archived Issues

New mouse model of MS reveals that oligodendroglia-specific connexin 47 regulates neuroinflammation

Matinas BioPharma initiates ENHANCE-IT study of MAT-9001

BioCryst initiates proof-of-concept trial of BCX-9930 in PNH

BITRAP demonstrates promising efficacy in preclinical models of rheumatoid arthritis

Servier publishes phase II data from RESTORE BRAIN study of S-44819

Phase I data for enzalutamide plus capivasertib in mCRPC

Enanta Pharmaceuticals patents MAP3K5 inhibitors

BenevolentAI Bio divulges new NTRK1 inhibitors

Blocking trash trashes MSI-hi tumors

Adlai Nortye describes hSTING receptor agonists

Il-Yang Pharmaceutical presents new antivirals

JAGUAHR Therapeutics patents new AhR antagonists

Indian approval of saroglitazar for noncirrhotic NASH

New gene fusion EWSR1-PATZ1 found in renal cell carcinoma

NCS-01 begins phase I/II study in patients with acute ischemic stroke

Enrollment open in phase I study of FT-596 for relapsed/refractory B-cell lymphoma or CLL

Gene therapy converts astrocytes into GABAergic neurons, alleviating motor deficits in HD models

Endocytosis inhibitor improves anticancer MAb efficacy

Gene rearrangements involving HMGA1/2 found in spindle cell/pleomorphic lipomas

Third cohort underway in phase I trial of Actimab-A plus CLAG-M for relapsed/refractory AML

Arcturus partners with Duke-NUS on COVID-19 vaccine development

Camrelizumab approved in China for advanced hepatocellular carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...